These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31210312)

  • 21. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
    Zhu J; Zhang Y; Yang X; Jin L
    Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-1269a acts as an onco-miRNA in non-small cell lung cancer via down-regulating SOX6.
    Jin RH; Yu DJ; Zhong M
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4888-4897. PubMed ID: 30070324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiRNA-488-3p inhibits malignant progression of NSCLC by modulating ADAM9.
    Wu Y; Wu Y; Chen XY; Niu YX; Lv FZ; Gao W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8893-8901. PubMed ID: 32964979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
    Yang Y; Huang XJ
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):213-221. PubMed ID: 31957834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
    Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G
    BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
    Li Q; Wu X; Guo L; Shi J; Li J
    FEBS Open Bio; 2019 Nov; 9(11):1983-1993. PubMed ID: 31587474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma.
    Xiao P; Liu WL
    Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA-300 suppresses proliferation, migration and invasion of non-small cell lung cancer via targeting ETS1.
    Yang YB; Tan H; Wang Q
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10827-10834. PubMed ID: 31858551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
    Fan X; Wu X
    J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
    Liao XH; Wang Y; Zhong B; Zhu SY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.
    Fang QY; Deng QF; Luo J; Zhou CC
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2548-2556. PubMed ID: 32196605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
    Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.
    Ma XR; Xu YL; Qian J; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1536-1544. PubMed ID: 30840276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propofol suppresses the progression of non‑small cell lung cancer via downregulation of the miR‑21‑5p/MAPK10 axis.
    Wu X; Li X; Xu G
    Oncol Rep; 2020 Aug; 44(2):487-498. PubMed ID: 32468043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA‑577 inhibits cell proliferation and invasion in non‑small cell lung cancer by directly targeting homeobox A1.
    Men L; Nie D; Nie H
    Mol Med Rep; 2019 Mar; 19(3):1875-1882. PubMed ID: 30628697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating MLLT11.
    Zhang HP; Chen QK; Xu JF
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
    Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.